BridgeBio Pharma, Inc.

Genetic-disease biopharma with commercial ATTR therapy and multiple targeted late-stage precision medicines.

Back to company catalog

Genetic & rare disease · Small molecules and precision genetic medicines · Commercial + NDA submitted

Compare report options